S

Stryker

Manufactures orthopedic and surgical medical devices

Production Team Leader

Full-TimeUpdated
$89.3k - $148.8k/yr
Mid, Senior
Bachelor's
Portage, MI, USA
In PersonOnsite; travel 0%.
Manufacturing & Production Operations
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • A bachelor's degree or six or more years of experience in lieu of the degree.
  • Four or more years of relevant experience.
Responsibilities
  • Lead daily manufacturing operations to achieve or exceed objectives for safety, quality, delivery, cost, customer experience, and people development.
  • Lead, coach, and develop team members while fostering a culture of engagement, accountability, collaboration, and continuous improvement.
  • Allocate labor and resources based on production schedules, capacity, priorities, and operational needs.
  • Use data, operational metrics, and business inputs to identify priorities, forecast needs, solve problems, and drive performance.
  • Anticipate production, equipment, and line-down risks and partner with cross-functional support teams to minimize disruptions.
  • Partner cross-functionally to resolve operational challenges, execute business priorities, and achieve value-stream goals.
  • Manage the technical and operational aspects of the business, using appropriate resources and structured problem-solving to resolve issues.
  • Identify and lead continuous improvement and cost-reduction initiatives, including Lean manufacturing and 6S activities.
  • Own Leader Standard Work and support audit requirements, including Quality and 6S.
  • Lead daily Managing for Daily Improvement activities through Tier 2 and communicate operational results and metrics effectively across the organization.
  • Provide coverage for the Operations Manager as needed, including participation in Managing for Daily Improvement Tier 3.
  • Manage team performance through coaching, development, talent reviews, performance reviews, and appropriate performance management.
  • Set clear performance expectations and hold team members accountable for achieving established goals.
  • Support the recruitment, selection, onboarding, and development of talent and anticipate temporary and permanent staffing needs.
  • Manage labor requirements, including overtime approval and timecard management.
  • Ensure team training compliance, competency tracking, and required recordkeeping.
  • Support new product implementation and production/capacity planning, as applicable.
  • Partner with other business leaders on operational and process-improvement initiatives.
  • Participate in audits and ensure compliance with applicable regulatory, quality, legal, corporate, and human resources policies and procedures.
  • May lead plant tours and maintain working knowledge of products manufactured across multiple production areas.
Desired Qualifications
  • Proven leadership experience in manufacturing or operations.
  • Experience with an enterprise resource planning/material requirements planning system.
  • Lean Management.
  • Microsoft suite.

About the company

Stryker makes medical devices for hospitals, surgical centers and emergency responders, spanning joint implants, surgical instruments and patient transport equipment. Its Mako platform assists surgeons with joint replacement, while its neurotechnology products support brain and spine procedures and stroke treatment. Clinicians use its equipment during surgery and emergency care, and the company earns money by selling implants, disposable products and capital equipment through direct sales teams and distributors. The business also supplies training and technical support for healthcare providers using its devices. Stryker was founded in 1941 and is headquartered in Portage, Michigan.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Get referred to Stryker

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Demand supports growth: July 2026 Stryker results show organic sales rose 9%, with reported sales reaching $6.6 billion.
  • Service extends equipment sales: Stryker's ProCare contracts bundle preventive maintenance, repairs and original manufacturer parts.
  • Relocation is available for Worcester technicians: Stryker's live transport service opening also lists 12 paid holidays.

What critics are saying

  • Operational failures reach customers: March 2026 cyberattack disrupted Stryker's ordering, manufacturing and shipping.
  • Older implants retain legal exposure: Stryker's recall estimates include Rejuvenate, LFIT V40 and legacy Wright hip products.
  • Field service demands travel: Stryker's northern Minnesota opening lists 80% travel plus evening or weekend call.

What makes Stryker unique

  • Mako combines imaging and physical guidance: Stryker uses CT-based planning and haptic boundaries during hip replacement.
  • Discarded devices return to service: Stryker's Sustainability Solutions reprocesses medical equipment for hospitals across the U.S. and Canada.
  • Transport extends its technology outside hospitals: Stryker's Power-LOAD supports stretchers while loading and unloading ambulances.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Medical & prescription plans
  • Supplemental health benefits
  • Flexible Spending accounts
  • Employee Assistance Program
  • Short-term & long-term disability
  • Tuition reimbursement
  • 401(k) plan
  • Employee Stock Purchase Plan

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Nov 1st, 2026
Stryker misses Q3 estimates with $6.52B revenue as orthopaedics slows and guidance is cut

Stryker missed Wall Street expectations in the third quarter of 2026, even as sales rose 7.6% year on year to $6.52 billion. Analysts had expected $6.62 billion. Adjusted earnings of $3.52 per share fell short of the $3.55 consensus. The medical technology company blamed a slowdown in US hip and knee replacements, citing patient affordability, more insurance pre-authorization denials, and problems after a new SAP system rollout. Operating margin fell to 15.9% from 18.7% a year earlier. Stryker cut its full-year adjusted earnings guidance to $14.85 per share at the midpoint, down 1.2%. It expects softness to continue, but is counting on product launches, robotics, and recent acquisitions, including ZuriMED, to drive growth. Shares trade at $296.17, down from $311.75 before the results.

Yahoo Finance
Oct 30th, 2026
Stryker shares fall 10% as 2026 sales guidance is cut to 6.5%-7.0% growth

Stryker shares fell about 10% to $279.98 before the open on Friday, after the medical device maker missed third-quarter estimates and cut its 2026 sales guidance. The stock was already down about 20% this year. Adjusted earnings per share were $3.52 against $3.55 expected. Revenue was $6.52 billion against $6.62 billion expected, up 7.6%. Stryker now expects 2026 organic sales growth of 6.5% to 7.0%, down from 8.3% to 9.3%. Its adjusted EPS guidance fell to $14.80 to $14.90 from $14.95 to $15.10. Chief executive officer Kevin Lobo said the Mako RPS hip and knee system is "off to a slow start." Spencer Stiles succeeds him and will issue the 2027 guidance early next year.

Yahoo Finance
Oct 29th, 2026
Stryker misses Q3 forecasts with $753M profit on $6.52B revenue

Stryker reported third-quarter profit of $753 million, or $1.96 per share, on Thursday. The Michigan-based medical device maker's adjusted earnings, which exclude asset impairment and amortisation costs, were $3.52 per share. Both results missed Wall Street forecasts. Analysts surveyed by Zacks Investment Research expected earnings of $3.56 per share and revenue of $6.58 billion; Stryker posted revenue of $6.52 billion. The company expects full-year earnings of $14.80 to $14.90 per share.

Associated Press
Oct 29th, 2026
Stryker Q3 sales rise 7.7% to $6.5B, but miss expectations; $3B added to buyback

Stryker reported third-quarter net sales of $6.5 billion, up 7.7% from a year earlier. Organic sales also rose 7.7%, driven mainly by higher unit volume. Reported net earnings fell 12.3% to $753 million, or $1.96 per diluted share, down 11.7%. Adjusted earnings per share rose 10.3% to $3.52, and adjusted operating margin rose 60 basis points to 26.2%. MedSurg and Neurotechnology sales grew 9.2% to $3.7 billion. Orthopaedics sales rose 5.7% to $2.9 billion. Chief executive officer Kevin A. Lobo said the results fell short of expectations, but he expects a solid fourth quarter. Stryker now expects 2026 organic sales growth of 6.5% to 7.0% and adjusted earnings per share of $14.80 to $14.90. It bought back $1.0 billion of stock in the quarter, and its board added $3.0 billion to the repurchase programme.

Yahoo Finance
Oct 28th, 2026
Stryker lags peers with 8.5% growth as plant problems, not hospitals, hit sales

Stryker's stock has lost 20.2% over the past 12 months, dividends included, while the S&P 500 returned 15.0%. Its revenue grew 8.5% over the latest four quarters, slower than four of its five peers, including Boston Scientific (13.5%) and Intuitive Surgical (20.5%). Management says hospital demand is steady. It blames the slowdown on a cybersecurity incident that halted manufacturing and on supply problems in peripheral vascular products. First-quarter fiscal 2026 revenue grew just 2.6%, and operating margin fell to 15.5%. Margin recovered to 25.2% in the second quarter. The stock fell 8.8% on September 8, 2026, after the chief financial officer said the vascular issue was unresolved. Third-quarter results are due October 29, 2026. Spencer Stiles will succeed Kevin Lobo as chief executive officer on January 1, 2027.